These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10997829)

  • 1. Prognostic factors of survival of HIV-infected patients with cytomegalovirus disease: Aquitaine Cohort, 1986-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).
    Binquet C; Saillour F; Bernard N; Rougier MB; Leger F; Bonnal F; Dabis F
    Eur J Epidemiol; 2000 May; 16(5):425-32. PubMed ID: 10997829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors of occurrence of cytomegalovirus disease and impact on survival in the Aquitaine Cohort in France, 1985 to 1994. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    Saillour F; Bernard N; Dequae-Merchadou L; Marimoutou C; Journot V; Dabis F
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Feb; 17(2):171-8. PubMed ID: 9473020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of HIV-infected patients with cytomegalovirus retinitis under highly active antiretroviral therapy. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    Binquet C; Saillour F; Bernard N; Marimoutou C; Dabis F
    AIDS; 1998 Dec; 12(18):2502-4. PubMed ID: 9875592
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic factors after non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus: Aquitaine Cohort, France, 1986-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).
    Thiessard F; Morlat P; Marimoutou C; Labouyrie E; Ragnaud JM; Pellegrin JL; Dupon M; Dabis F
    Cancer; 2000 Apr; 88(7):1696-702. PubMed ID: 10738229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    Chêne G; Binquet C; Moreau JF; Neau D; Pellegrin I; Malvy D; Ceccaldi J; Lacoste D; Dabis F
    AIDS; 1998 Dec; 12(17):2313-20. PubMed ID: 9863874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of cytomegalovirus disease in the Aquitaine cohort of HIV-infected patients: a retrospective survey, 1987-1993. Groupe d'Epidémilogie Clinique du SIDA en Aquitaine (GECSA).
    Saillour F; Bernard N; Ragnaud JM; Morlat P; Blanchard Y; Monlun E; Labouyrie E; Chene G; Dabis F
    J Infect; 1997 Sep; 35(2):155-61. PubMed ID: 9354350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum triglycerides, HIV infection, and highly active antiretroviral therapy, Aquitaine Cohort, France, 1996 to 1998. Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA).
    Thiébaut R; Dabis F; Malvy D; Jacqmin-Gadda H; Mercié P; ValentinVD
    J Acquir Immune Defic Syndr; 2000 Mar; 23(3):261-5. PubMed ID: 10839662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual nucleoside regimens in nonadvanced HIV infection: prospective follow-up of 130 patients, Aquitaine Cohort, 1996 to 1998. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).
    Morlat P; Marimoutou C; Dequae-Merchadou L; Pellegrin I; Mercié P; Neau D; Beylot J; Dabis F
    J Acquir Immune Defic Syndr; 2000 Mar; 23(3):255-60. PubMed ID: 10839661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid change in the use of antiretroviral agents and improvement in a population of HIV-infected patients: France, 1995-1997. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).
    Spira R; Marimoutou C; Binquet C; Lacoste D; Dabis F
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(4):358-64. PubMed ID: 9704941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthropometric indices as predictors of survival in AIDS adults. Aquitaine Cohort, France, 1985-1997. Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA).
    Thiébaut R; Malvy D; Marimoutou C; Davis F
    Eur J Epidemiol; 2000; 16(7):633-9. PubMed ID: 11078120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women and HIV infection: a cohort study of 483 HIV-infected women in Bordeaux, France, 1985-1991. The Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.
    Morlat P; Parneix P; Douard D; Lacoste D; Dupon M; Chêne G; Pellegrin JL; Ragnaud JM; Dabis F
    AIDS; 1992 Oct; 6(10):1187-93. PubMed ID: 1466851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of human immunodeficiency virus infection in patients with tuberculosis disease. A cohort study in Bordeaux, France, 1988-1994. The Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA).
    Leroy V; Salmi LR; Dupon M; Sentilhes A; Texier-Maugein J; Dequae L; Dabis F; Salamon R
    Am J Epidemiol; 1997 Feb; 145(4):293-300. PubMed ID: 9054232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cohort study of 89 HIV-1-infected adult patients contaminated by blood products: Bordeaux 1981-1989. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).
    Msellati P; Dupon M; Morlat P; Lacoste D; Pellegrin JL; Dabis F
    AIDS; 1990 Nov; 4(11):1105-9. PubMed ID: 2282183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease inhibitor therapy is associated with markedly prolonged time to relapse and improved survival in AIDS patients with cytomegalovirus retinitis.
    Skiest DJ; Chiller T; Chiller K; Park A; Keiser P
    Int J STD AIDS; 2001 Oct; 12(10):659-64. PubMed ID: 11564333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CD8 hyperlymphocytosis in HIV infection. 63 cases. GECSA (Groupe d'Epidémiologie Clinique du SIDA en Aquitaine)].
    Constans J; Ladner J; Dabis F; Brossard G; Commenges D; Leng B; Conri C
    Presse Med; 1992 Jan 4-11; 21(1):27-30. PubMed ID: 1531260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of AIDS-associated cytomegalovirus colitis in the era of potent antiretroviral therapy.
    Bini EJ; Gorelick SM; Weinshel EH
    J Clin Gastroenterol; 2000 Jun; 30(4):414-9. PubMed ID: 10875471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disseminated Mycobacterium avium complex infections in AIDS. Apropos of 100 cases. Groupe d'Epidémiologie clinique du SIDA en Aquitaine].
    Lasseur C; Maugein J; Pellegrin JL; Dupon M; Ragnaud JM; Morlat P; Pellegrin I; Constans J; Monlun E; Chene G
    Rev Med Interne; 1995; 16(2):110-20. PubMed ID: 7709100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital-based surveillance of HIV infection: epidemiological trends in Bordeaux, France 1983-1989. The Groupe D'epidémiologie Clinique du SIDA en Aquitaine (GECSA).
    Chêne G; Dabis F; Salamon R
    Eur J Epidemiol; 1992 Jan; 8(1):58-66. PubMed ID: 1572432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Human immunodeficiency virus infection and AIDS in Aquitaine. 10 years' experience of a hospital information system, 1985-1995. Le Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GECSA)].
    Marimoutou C; Chêne G; Dabis F; Lacoste D; Salamon R
    Presse Med; 1997 May 3-10; 26(15):703-10. PubMed ID: 9183368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].
    Cartón JA; Maradona JA; de Oña M; Asensi V; Melón S; García-Alcalde ML; Rodríguez-Junquera M; Moreno-Torrico A; de Zárraga M
    Med Clin (Barc); 1999 Sep; 113(6):205-9. PubMed ID: 10472608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.